Search research articles
Contact Us
Filters
Showing results (21-30 of 361) with videos related to
Page
of 37
Sort By:
Vaccine
|
December 4, 2020
Corrigendum to "Getting the most from the Ebola vaccine success" [Vaccine 33 (2015) 7141]
Daniele Focosi, Fabrizio Maggi, Mauro Pistello
Reviews in Medical Virology
|
January 15, 2026
Microplastics and Nanoplastics as Carriers for Viral Transmission: Effects on Viral Properties, Infection, Immune Response, and Public Health
Cosmina Mija, Giuseppe Sberna, Fabrizio Maggi
The New Microbiologica
|
March 11, 2016
Ebolavirus and evidence-based speculations
Daniele Focosi, Guido Antonelli, Fabrizio Maggi
Intervirology
|
November 10, 2024
The Fitness of Molnupiravir-Signed SARS-CoV-2 Variants: Imputation Analysis Based on Prescription Counts and Global Initiative on Sharing All Influenza Data Analyses by Country
Daniele Focosi, Dave McNally, Fabrizio Maggi
Vaccines
|
March 26, 2022
Modified Hemagglutination Tests for COVID-19 Serology in Resource-Poor Settings: Ready for Prime-Time?
Daniele Focosi, Massimo Franchini, Fabrizio Maggi
International Journal of Molecular Sciences
|
November 25, 2023
Virus-Encoded Circular RNAs: Role and Significance in Viral Infections
Giuseppe Sberna, Fabrizio Maggi, Alessandra Amendola
Reviews in Medical Virology
|
August 2, 2019
Progressive multifocal leukoencephalopathy and anti-CD20 monoclonal antibodies: What do we know after 20 years of rituximab
Daniele Focosi, Marco Tuccori, Fabrizio Maggi
Vaccine
|
November 12, 2015
Getting the most from the Ebola vaccine success
Daniele Focosi, Fabrizio Maggi, Mauro Pistello
Current Drug Targets
|
August 7, 2015
How Current Direct-Acting Antiviral and Novel Cell Culture Systems for HCV are Shaping Therapy and Molecular Diagnosis of Chronic HCV Infection?
Fabrizio Maggi, Daniele Focosi, Mauro Pistello
Viruses
|
February 26, 2022
Mucosal Vaccines, Sterilizing Immunity, and the Future of SARS-CoV-2 Virulence
Daniele Focosi, Fabrizio Maggi, Arturo Casadevall
Page
of 37
Search research articles
Search
Showing results (21-30 of 361) with videos related to
Sort By:
Page
of 37
Vaccine
|
December 4, 2020
Corrigendum to "Getting the most from the Ebola vaccine success" [Vaccine 33 (2015) 7141]
Daniele Focosi, Fabrizio Maggi, Mauro Pistello
Reviews in Medical Virology
|
January 15, 2026
Microplastics and Nanoplastics as Carriers for Viral Transmission: Effects on Viral Properties, Infection, Immune Response, and Public Health
Cosmina Mija, Giuseppe Sberna, Fabrizio Maggi
The New Microbiologica
|
March 11, 2016
Ebolavirus and evidence-based speculations
Daniele Focosi, Guido Antonelli, Fabrizio Maggi
Intervirology
|
November 10, 2024
The Fitness of Molnupiravir-Signed SARS-CoV-2 Variants: Imputation Analysis Based on Prescription Counts and Global Initiative on Sharing All Influenza Data Analyses by Country
Daniele Focosi, Dave McNally, Fabrizio Maggi
Vaccines
|
March 26, 2022
Modified Hemagglutination Tests for COVID-19 Serology in Resource-Poor Settings: Ready for Prime-Time?
Daniele Focosi, Massimo Franchini, Fabrizio Maggi
International Journal of Molecular Sciences
|
November 25, 2023
Virus-Encoded Circular RNAs: Role and Significance in Viral Infections
Giuseppe Sberna, Fabrizio Maggi, Alessandra Amendola
Reviews in Medical Virology
|
August 2, 2019
Progressive multifocal leukoencephalopathy and anti-CD20 monoclonal antibodies: What do we know after 20 years of rituximab
Daniele Focosi, Marco Tuccori, Fabrizio Maggi
Vaccine
|
November 12, 2015
Getting the most from the Ebola vaccine success
Daniele Focosi, Fabrizio Maggi, Mauro Pistello
Current Drug Targets
|
August 7, 2015
How Current Direct-Acting Antiviral and Novel Cell Culture Systems for HCV are Shaping Therapy and Molecular Diagnosis of Chronic HCV Infection?
Fabrizio Maggi, Daniele Focosi, Mauro Pistello
Viruses
|
February 26, 2022
Mucosal Vaccines, Sterilizing Immunity, and the Future of SARS-CoV-2 Virulence
Daniele Focosi, Fabrizio Maggi, Arturo Casadevall
Page
of 37